» Articles » PMID: 4977282

Human Immunity to the Meningococcus. 3. Preparation and Immunochemical Properties of the Group A, Group B, and Group C Meningococcal Polysaccharides

Overview
Journal J Exp Med
Date 1969 Jun 1
PMID 4977282
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

The group-specific polysaccharides of group A and group C meningococci have been isolated by a new procedure which employs the cationic detergent Cetavlon to precipitate these polysaccharides from the whole culture. The A and C polysaccharide prepared by this method are noteworthy because they are of high molecular weight. The main constituent of the A polysaccharide is N-acetyl, O-acetyl mannosamine phosphate; of the C polysaccharide N-acetyl, O-acetyl neuraminic acid. This purification procedure, when applied to cultures of group B organisms, yields a polysaccharide consisting primarily of N-acetyl neuraminic acid. A passive hemagglutination test developed to measure antibodies to the polysaccharides demonstrated the specificity of these antigens. Using a hemagglutination inhibition test, these antigens were again found to be group-specific, and this test could be used for serogrouping meningococcal isolates.

Citing Articles

A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.

Biselli R, Nisini R, Lista F, Autore A, Lastilla M, De Lorenzo G Biomedicines. 2022; 10(8).

PMID: 36009598 PMC: 9405556. DOI: 10.3390/biomedicines10082050.


Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.

Martins R, Perisse A, Camacho L, Leal M, Maia M, Homma A Braz J Infect Dis. 2021; 25(6):101652.

PMID: 34793713 PMC: 9392203. DOI: 10.1016/j.bjid.2021.101652.


Development of vaccines at the time of COVID-19.

Almond J, Hacker J, Harwood C, Pizza M, Rappuoli R, Ron E Microlife. 2021; 1(1):uqaa003.

PMID: 34235437 PMC: 7798935. DOI: 10.1093/femsml/uqaa003.


The COVID-19 Vaccine Landscape.

Koch T, Fathi A, Addo M Adv Exp Med Biol. 2021; 1318:549-573.

PMID: 33973199 DOI: 10.1007/978-3-030-63761-3_31.


Complement factor D haplodeficiency is associated with a reduced complement activation speed and diminished bacterial killing.

Langereis J, van der Molen R, de Kat Angelino C, Henriet S, de Jonge M, Joosten I Clin Transl Immunology. 2021; 10(4):e1256.

PMID: 33841879 PMC: 8019133. DOI: 10.1002/cti2.1256.


References
1.
Menzel A, RAKE G . STUDIES ON MENINGOCOCCAL INFECTION : XII. IMMUNOCHEMICAL STUDIES ON MENINGOCOCCUS TYPE II. J Exp Med. 2009; 75(4):437-52. PMC: 2135261. DOI: 10.1084/jem.75.4.437. View

2.
Mokrasch L . Analysis of hexose phosphates and sugar mixtures with the anthrone reagent. J Biol Chem. 1954; 208(1):55-9. View

3.
BLACKLOW R, Warren L . Biosynthesis of sialic acids by Neisseria meningitidis. J Biol Chem. 1962; 237:3520-6. View

4.
Watson R, SCHERP H . The specific hapten of group C (group II alpha) meningococcus. I. Preparation and immunological behavior. J Immunol. 1958; 81(4):331-6. View

5.
Watson R, Marinetti G, SCHERP H . The specific hapten of group C (group II alpha) meningococcus. II. Chemical nature. J Immunol. 1958; 81(4):337-44. View